These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9040189)

  • 21. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years].
    Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM
    An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
    Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
    Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.
    Peters JH
    Gastrointest Endosc; 2010 Apr; 71(4):704-5. PubMed ID: 20363412
    [No Abstract]   [Full Text] [Related]  

  • 25. Barrett's esophagus-is it bad for your health?
    Falk GW
    Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and surveillance of Barrett's esophagus.
    Regula J
    Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
    Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
    Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus?
    Wani S; Sharma P
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):128-9. PubMed ID: 18237863
    [No Abstract]   [Full Text] [Related]  

  • 30. Barrett's esophagus progressing to cancer: a needle in a haystack?
    Lewis JJ; Rubenstein JH
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):194-5. PubMed ID: 21145422
    [No Abstract]   [Full Text] [Related]  

  • 31. Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis.
    Rubenstein JH; Waljee AK; Dwamena B; Bergman J; Vieth M; Wani S
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1529-1530. PubMed ID: 29307847
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the incidence of esophageal adenocarcinomas in patients with Barrett's esophagus really overestimated?
    Younes M
    Gastroenterology; 2005 Dec; 129(6):2125-6; author reply 2126. PubMed ID: 16344087
    [No Abstract]   [Full Text] [Related]  

  • 37. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenocarcinoma in Barrett's esophagus.
    Altorki NK; Skinner DB
    Semin Surg Oncol; 1990; 6(5):274-8. PubMed ID: 2237086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-grade dysplasia in Barrett's esophagus.
    Odze RD; Goldblum JR
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1419-20; author reply 1420. PubMed ID: 17110303
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of esophageal adenocarcinoma].
    Triboulet JP; Guillem P
    Ann Chir; 1998; 52(5):421-4. PubMed ID: 9752480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.